Kwon W, Ham C, Byun J, Jeong J, Ko M, Lee S
Korean J Neurotrauma. 2025; 20(4):225-233.
PMID: 39803341
PMC: 11711025.
DOI: 10.13004/kjnt.2024.20.e44.
Marques Dantas R, Vilela D, Melo M, Fernandes G, Lemos N, Faber J
Front Hum Neurosci. 2024; 18:1478423.
PMID: 39734668
PMC: 11671511.
DOI: 10.3389/fnhum.2024.1478423.
Quinones C, Wilson Jr J, Kumbhare D, Guthikonda B, Hoang S
J Clin Med. 2024; 13(19).
PMID: 39407779
PMC: 11477398.
DOI: 10.3390/jcm13195719.
Abd-Elsayed A, Robinson C, Shehata P, Koh Y, Patel M, Fiala K
Biomedicines. 2024; 12(4).
PMID: 38672076
PMC: 11047848.
DOI: 10.3390/biomedicines12040720.
Jang K, Garraway S
Neurobiol Pain. 2024; 15:100151.
PMID: 38314104
PMC: 10837099.
DOI: 10.1016/j.ynpai.2024.100151.
Broadening horizons: ferroptosis as a new target for traumatic brain injury.
Wei Z, Yu H, Zhao H, Wei M, Xing H, Pei J
Burns Trauma. 2024; 12:tkad051.
PMID: 38250705
PMC: 10799763.
DOI: 10.1093/burnst/tkad051.
Outcomes of Operative Treatment of Traumatic Spinal Injuries: 2-Year Follow-Up.
Mahmoodkhani M, Rezvani M, Farshin A, Ghasemi P, Sheibani Tehrani D
Adv Biomed Res. 2023; 12:217.
PMID: 38073749
PMC: 10699229.
DOI: 10.4103/abr.abr_82_23.
The Role of Exosomes from Mesenchymal Stem Cells in Spinal Cord Injury: A Systematic Review.
Wang H, Zhao C, Rong Q, Cao J, Chen H, Li R
Int J Stem Cells. 2023; 17(3):236-252.
PMID: 38016704
PMC: 11361850.
DOI: 10.15283/ijsc23092.
Cervical Myelocystocele: A One-in-50,000 Congenital Abnormality of the Spinal Cord.
Msheik A, Abbass D, Bayram M, Awde A, Al Mokdad Z
Cureus. 2023; 15(4):e37278.
PMID: 37168187
PMC: 10165719.
DOI: 10.7759/cureus.37278.
Therapeutic potential of small extracellular vesicles derived from mesenchymal stem cells for spinal cord and nerve injury.
Lim Y, Jung G, Park W, Seo M, Lee G
Front Cell Dev Biol. 2023; 11:1151357.
PMID: 37035240
PMC: 10073723.
DOI: 10.3389/fcell.2023.1151357.
Long-term assessment of the functional independence measure in sports-related spinal cord injury.
Pozin M, Najafali D, Naik A, MacInnis B, Subbarao N, Zuckerman S
J Spinal Cord Med. 2023; 47(2):214-228.
PMID: 36977319
PMC: 10885752.
DOI: 10.1080/10790268.2023.2167903.
Can a Scaffold Enriched with Mesenchymal Stem Cells Be a Good Treatment for Spinal Cord Injury?.
Blando S, Anchesi I, Mazzon E, Gugliandolo A
Int J Mol Sci. 2022; 23(14).
PMID: 35886890
PMC: 9319719.
DOI: 10.3390/ijms23147545.
Electroacupuncture for Spinal Cord Injury: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Tan J, Meng F, Zhang B, Deng Q, Jiao B, Peng L
Evid Based Complement Alternat Med. 2022; 2022:8040555.
PMID: 35280510
PMC: 8916891.
DOI: 10.1155/2022/8040555.
Management of Acute Traumatic Spinal Cord Injury: A Review of the Literature.
Wang T, Park C, Zhang H, Rahimpour S, Murphy K, Goodwin C
Front Surg. 2021; 8:698736.
PMID: 34966774
PMC: 8710452.
DOI: 10.3389/fsurg.2021.698736.
Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury.
Kim G, Sung S, Kang K, Choi J, Lee S, Sung M
Int J Mol Sci. 2021; 22(24).
PMID: 34948463
PMC: 8703906.
DOI: 10.3390/ijms222413672.
Mesenchymal Stem Cells in Treatment of Spinal Cord Injury and Amyotrophic Lateral Sclerosis.
Sykova E, Cizkova D, Kubinova S
Front Cell Dev Biol. 2021; 9:695900.
PMID: 34295897
PMC: 8290345.
DOI: 10.3389/fcell.2021.695900.
Impact of Dual Cell Co-culture and Cell-conditioned Media on Yield and Function of a Human Olfactory Cell Line for Regenerative Medicine.
Wood R, Durali P, Wall I
Bioengineering (Basel). 2020; 7(2).
PMID: 32290611
PMC: 7355638.
DOI: 10.3390/bioengineering7020037.
C2-C3 spinal fracture subluxation with ligamentous and vascular injury: a case report and review of management.
Alexander H, Dowlati E, McGowan J, Mason R, Anaizi A
Spinal Cord Ser Cases. 2019; 5:4.
PMID: 30675388
PMC: 6335400.
DOI: 10.1038/s41394-019-0150-7.